About
Our Company

Management

Board of Directors

Scientific Advisory Board

Partners

About TScan

TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.
Technology
Our Approach

TargetScan

ReceptorScan

T-Integrate Cell Engineering

Publications

Technology

TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.
Investors and Media
Pipeline
Careers

Unleash immunity

TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.

How We're Different

News

TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

News

TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

News

TScan Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference